 Tilray Inc NASDAQ:TLRY remained on the Buy list at Canaccord Genuity TSX:CF, LSE:CF but analysts cut their price target following a weaker-than-anticipated second quarter print. In a note the broker said the results, combined with the recent softening of US federal catalysts following the conclusion of the congressional lame-duck session, which ultimately did not advance any cannabis reforms had prompted it to reduce its target to US5 from US7. 